BRIAN G ROSE MD
Prescription History 1093845513
Internal Medicine - Endocrinology, Diabetes & Metabolism in Bozeman, MT


Quality Rating: 80.8 out of 100 score

NPI Status: Active since March 06, 2007

Contact Information

931 HIGHLAND BLVD STE 3350
BOZEMAN, MT
ZIP 59715
Phone: (406) 414-5331

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for BRIAN G ROSE MD, an active Endocrinology, Diabetes & Metabolism specialist practicing in Bozeman, MT. Our medical registry currently tracks 55 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,350 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 326 claims alone.


Alendronate Sodium

Generic Formulation: Alendronate SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 96
30-Day Fills 258.0
Days Supply 7,728
MT State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills88.6
Peer Average Days Supply2,604
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 140.0% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $933.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.73

State Avg Cost Per Claim

$8.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis.

Therapeutic Applications

Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates.

Amitriptyline Hcl

Generic Formulation: Amitriptyline HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 19
30-Day Fills 43.7
Days Supply 1,310
MT State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills45.9
Peer Average Days Supply1,336
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $188.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.90

State Avg Cost Per Claim

$20.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters such as serotonin) in the brain.

Amlodipine Besylate

Generic Formulation: Amlodipine BesylateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 31
30-Day Fills 88.0
Days Supply 2,640
MT State Average Benchmarks
Peer Average Claims101.0
Peer Average 30-Day Fills236.3
Peer Average Days Supply6,962
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 69.3% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $204.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.60

State Avg Cost Per Claim

$6.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.

Therapeutic Applications

Amlodipine is used with or without other medications to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor.

Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 95
30-Day Fills 272.5
Days Supply 8,174
MT State Average Benchmarks
Peer Average Claims140.0
Peer Average 30-Day Fills333.3
Peer Average Days Supply9,764
Conservative Utilization

This provider writes prescriptions for this formulation 32.1% less frequently than the standard regional baseline metric for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,629.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.15

State Avg Cost Per Claim

$11.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Basaglar Kwikpen U-100

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 21
30-Day Fills 53.6
Days Supply 1,608
MT State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills38.0
Peer Average Days Supply1,070
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,960.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$426.71

State Avg Cost Per Claim

$443.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Cabergoline

Generic Formulation: CabergolineSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 17
30-Day Fills 41.2
Days Supply 1,233
MT State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills32.2
Peer Average Days Supply950
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,374.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$139.68

State Avg Cost Per Claim

$120.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An ergoline derivative and dopamine D2-agonist that inhibits PROLACTIN secretion. It is used in the management of HYPERPROLACTINEMIA, and to suppress lactation following childbirth for medical reasons. Cabergoline is also used in the management of PARKINSON DISEASE.

Therapeutic Applications

This medication is used to treat high levels of prolactin hormone in your body. High levels of prolactin in women can cause symptoms such as unwanted breast milk and missed periods and can cause difficulty becoming pregnant. High levels of prolactin in men can cause symptoms such as enlarged breasts and decreased sexual ability/desire. Cabergoline is an ergot medication and works by blocking the release of prolactin from the pituitary gland.

Dexamethasone

Generic Formulation: DexamethasoneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 16
MT State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills28.6
Peer Average Days Supply466
Conservative Utilization

This provider writes prescriptions for this formulation 36.0% less frequently than the standard regional baseline metric for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$0.69

State Avg Cost Per Claim

$17.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory 9-fluoro-glucocorticoid.

Therapeutic Applications

Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Droplet Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 20
30-Day Fills 62.6
Days Supply 1,880
MT State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills47.3
Peer Average Days Supply1,409
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,289.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$114.46

State Avg Cost Per Claim

$76.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Fludrocortisone Acetate

Generic Formulation: Fludrocortisone AcetateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 13
30-Day Fills 39.0
Days Supply 1,170
MT State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills26.7
Peer Average Days Supply665
Conservative Utilization

This provider writes prescriptions for this formulation 35.0% less frequently than the standard regional baseline metric for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $685.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$52.75

State Avg Cost Per Claim

$20.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Fludrocortisone is a man-made form of a natural substance (glucocorticoid) made by the body. It is used along with other medications (such as hydrocortisone) to treat low glucocorticoid levels caused by disease of the adrenal gland (such as Addison's disease, adrenocortical insufficiency, salt-losing adrenogenital syndrome). Glucocorticoids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. They are also needed to break down carbohydrates in your diet.

Forteo

Generic Formulation: TeriparatideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 450
MT State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills18.1
Peer Average Days Supply519
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $68,645.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$4,576.37

State Avg Cost Per Claim

$4,394.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

Therapeutic Applications

Teriparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication is not recommended for use in children or young adults whose bones are still growing.

Furosemide

Generic Formulation: FurosemideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 11
30-Day Fills 26.7
Days Supply 801
MT State Average Benchmarks
Peer Average Claims68.0
Peer Average 30-Day Fills123.6
Peer Average Days Supply3,454
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 83.8% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $50.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.56

State Avg Cost Per Claim

$5.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.

Therapeutic Applications

Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

Gabapentin

Generic Formulation: GabapentinSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 36.0
Days Supply 1,080
MT State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills120.3
Peer Average Days Supply3,396
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.4% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $287.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.93

State Avg Cost Per Claim

$17.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Glimepiride

Generic Formulation: GlimepirideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 33
30-Day Fills 96.0
Days Supply 2,880
MT State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills77.9
Peer Average Days Supply2,269
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $683.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.70

State Avg Cost Per Claim

$11.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.

Therapeutic Applications

Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide

Generic Formulation: GlipizideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 12
30-Day Fills 29.6
Days Supply 887
MT State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills56.0
Peer Average Days Supply1,627
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.0% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $52.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.38

State Avg Cost Per Claim

$7.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Humalog

Generic Formulation: Insulin LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 27
30-Day Fills 63.7
Days Supply 1,759
MT State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills39.1
Peer Average Days Supply1,107
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $33,696.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,248.01

State Avg Cost Per Claim

$1,007.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 58
30-Day Fills 125.9
Days Supply 3,682
MT State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills46.8
Peer Average Days Supply1,265
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 114.8% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $67,639.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,166.19

State Avg Cost Per Claim

$857.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Mix 75-25 Kwikpen

Generic Formulation: Insulin Lispro Protamin/LisproSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 11
30-Day Fills 23.5
Days Supply 703
MT State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills19.0
Peer Average Days Supply525
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,141.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,194.69

State Avg Cost Per Claim

$1,087.35

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Hydrochlorothiazide

Generic Formulation: HydrochlorothiazideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 27
30-Day Fills 80.0
Days Supply 2,400
MT State Average Benchmarks
Peer Average Claims65.0
Peer Average 30-Day Fills159.5
Peer Average Days Supply4,722
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.5% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $178.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.60

State Avg Cost Per Claim

$4.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.

Therapeutic Applications

This medication is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/water pills. It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet.

Hydrocortisone

Generic Formulation: HydrocortisoneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 91
30-Day Fills 209.6
Days Supply 6,268
MT State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills35.0
Peer Average Days Supply866
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 237.0% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,279.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$69.00

State Avg Cost Per Claim

$23.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

Therapeutic Applications

Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal.

Insulin Syringe

Generic Formulation: Syringe-Needle,insulin,0.5 MlSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 38.6
Days Supply 1,137
MT State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills25.7
Peer Average Days Supply745
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,134.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$81.05

State Avg Cost Per Claim

$32.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Insulin Syringe

Generic Formulation: Syringe And Needle,insulin,1mlSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 11
30-Day Fills 28.4
Days Supply 841
MT State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills25.7
Peer Average Days Supply745
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $927.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$84.29

State Avg Cost Per Claim

$32.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Jardiance

Generic Formulation: EmpagliflozinSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 75
30-Day Fills 171.0
Days Supply 5,108
MT State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills50.3
Peer Average Days Supply1,445
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 158.6% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $106,612.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,421.51

State Avg Cost Per Claim

$988.26

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys.

Lantus

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 28
30-Day Fills 62.5
Days Supply 1,824
MT State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills26.8
Peer Average Days Supply740
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 55.6% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $35,667.64 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,273.84

State Avg Cost Per Claim

$654.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Lantus Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 125
30-Day Fills 328.1
Days Supply 9,814
MT State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills55.2
Peer Average Days Supply1,576
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 331.0% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $121,723.89 across this reporting matrix range.

Provider Avg Cost Per Claim

$973.79

State Avg Cost Per Claim

$666.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Levemir

Generic Formulation: Insulin DetemirSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 19
30-Day Fills 32.1
Days Supply 917
MT State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills20.5
Peer Average Days Supply484
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $29,885.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,572.94

State Avg Cost Per Claim

$562.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide).

Levemir Flexpen

Generic Formulation: Insulin DetemirSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 32
30-Day Fills 73.9
Days Supply 2,214
MT State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$1,097.97

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide).

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 326
30-Day Fills 895.1
Days Supply 26,828
MT State Average Benchmarks
Peer Average Claims142.0
Peer Average 30-Day Fills316.9
Peer Average Days Supply9,209
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 129.6% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,568.25 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.08

State Avg Cost Per Claim

$14.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Lisinopril

Generic Formulation: LisinoprilSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 46
30-Day Fills 130.0
Days Supply 3,900
MT State Average Benchmarks
Peer Average Claims106.0
Peer Average 30-Day Fills248.6
Peer Average Days Supply7,296
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 56.6% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $474.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.32

State Avg Cost Per Claim

$7.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

Therapeutic Applications

Lisinopril is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily.

Losartan Potassium

Generic Formulation: Losartan PotassiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 16
30-Day Fills 44.0
Days Supply 1,320
MT State Average Benchmarks
Peer Average Claims103.0
Peer Average 30-Day Fills240.8
Peer Average Days Supply7,113
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 84.5% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $164.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.29

State Avg Cost Per Claim

$11.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

Therapeutic Applications

Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Metformin Hcl

Generic Formulation: Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 85
30-Day Fills 227.3
Days Supply 6,783
MT State Average Benchmarks
Peer Average Claims67.0
Peer Average 30-Day Fills151.2
Peer Average Days Supply4,412
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 26.9% more claims than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,276.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.02

State Avg Cost Per Claim

$7.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Metformin Hcl Er

Generic Formulation: Metformin HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 103
30-Day Fills 289.3
Days Supply 8,617
MT State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills98.2
Peer Average Days Supply2,868
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 134.1% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,251.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.86

State Avg Cost Per Claim

$9.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Methimazole

Generic Formulation: MethimazoleSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 103
30-Day Fills 293.7
Days Supply 8,812
MT State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills59.1
Peer Average Days Supply1,680
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 232.3% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,950.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.94

State Avg Cost Per Claim

$11.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme.

Therapeutic Applications

Methimazole is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone.

Nano 2nd Gen Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 55
30-Day Fills 147.4
Days Supply 4,416
MT State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills59.1
Peer Average Days Supply1,747
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 111.5% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,798.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$87.24

State Avg Cost Per Claim

$99.53

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Novolin 70-30

Generic Formulation: Insulin Nph Hum/Reg Insulin HmSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 23
30-Day Fills 41.0
Days Supply 1,199
MT State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills19.3
Peer Average Days Supply505
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 64.3% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $29,721.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,292.23

State Avg Cost Per Claim

$573.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Novolog

Generic Formulation: Insulin AspartSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 33
30-Day Fills 66.7
Days Supply 1,823
MT State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills34.3
Peer Average Days Supply959
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 57.1% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $65,242.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,977.05

State Avg Cost Per Claim

$1,004.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Novolog Flexpen

Generic Formulation: Insulin AspartSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 101
30-Day Fills 207.3
Days Supply 6,154
MT State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills49.3
Peer Average Days Supply1,344
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 248.3% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $134,497.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,331.66

State Avg Cost Per Claim

$955.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Omnipod 5 G6 Pods (Gen 5)

Generic Formulation: Insulin Pump Cart,automated,btSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 11
30-Day Fills 33.0
Days Supply 990
MT State Average Benchmarks
Peer Average Claims12.0
Peer Average 30-Day Fills18.0
Peer Average Days Supply540
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,871.12 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,988.28

State Avg Cost Per Claim

$904.54

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ozempic

Generic Formulation: SemaglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 29
30-Day Fills 52.3
Days Supply 1,542
MT State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills42.3
Peer Average Days Supply1,227
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $51,758.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,784.79

State Avg Cost Per Claim

$1,316.48

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Pioglitazone Hcl

Generic Formulation: Pioglitazone HclSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 13
30-Day Fills 38.3
Days Supply 1,150
MT State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills64.3
Peer Average Days Supply1,899
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.2% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $511.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.33

State Avg Cost Per Claim

$15.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone.

Potassium Chloride

Generic Formulation: Potassium ChlorideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 33.0
Days Supply 974
MT State Average Benchmarks
Peer Average Claims67.0
Peer Average 30-Day Fills124.6
Peer Average Days Supply3,537
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 79.1% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $224.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.06

State Avg Cost Per Claim

$27.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.

Therapeutic Applications

This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with water pills/diuretics.

Prednisone

Generic Formulation: PrednisoneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 18
30-Day Fills 46.5
Days Supply 1,368
MT State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills47.3
Peer Average Days Supply936
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.4% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $206.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.45

State Avg Cost Per Claim

$6.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Rosuvastatin Calcium

Generic Formulation: Rosuvastatin CalciumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 36.7
Days Supply 1,102
MT State Average Benchmarks
Peer Average Claims60.0
Peer Average 30-Day Fills148.2
Peer Average Days Supply4,408
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 76.7% less volume than the regional standard for practitioners inside MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $751.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$53.71

State Avg Cost Per Claim

$24.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.

Therapeutic Applications

Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details.

Synthroid

Generic Formulation: Levothyroxine SodiumSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 27
30-Day Fills 76.2
Days Supply 2,286
MT State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills54.0
Peer Average Days Supply1,606
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,800.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$103.74

State Avg Cost Per Claim

$74.50

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Testosterone

Generic Formulation: TestosteroneSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 25
30-Day Fills 52.1
Days Supply 1,564
MT State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills23.0
Peer Average Days Supply640
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 47.1% more claims than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,302.82 across this reporting matrix range.

Provider Avg Cost Per Claim

$292.11

State Avg Cost Per Claim

$211.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.

Therapeutic Applications

This medicated patch contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women.

Testosterone Cypionate

Generic Formulation: Testosterone CypionateSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 34
30-Day Fills 73.3
Days Supply 2,184
MT State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills29.6
Peer Average Days Supply841
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 88.9% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,107.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$62.00

State Avg Cost Per Claim

$45.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used in men who do not make enough of a natural substance called testosterone. In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. It may also be used to treat certain types of breast cancer in women.

Toujeo Max Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 18
30-Day Fills 35.8
Days Supply 1,055
MT State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills33.9
Peer Average Days Supply883
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $34,025.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,890.31

State Avg Cost Per Claim

$1,189.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Toujeo Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 45
30-Day Fills 94.9
Days Supply 2,789
MT State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills33.9
Peer Average Days Supply978
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 136.8% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $40,130.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$891.78

State Avg Cost Per Claim

$811.97

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Tresiba Flextouch U-100

Generic Formulation: Insulin DegludecSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 20
30-Day Fills 63.3
Days Supply 1,899
MT State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills46.5
Peer Average Days Supply1,348
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,298.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$814.95

State Avg Cost Per Claim

$700.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Tresiba Flextouch U-200

Generic Formulation: Insulin DegludecSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 44
30-Day Fills 94.1
Days Supply 2,804
MT State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills43.9
Peer Average Days Supply1,263
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 76.0% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $67,220.51 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,527.74

State Avg Cost Per Claim

$1,230.17

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Trulicity

Generic Formulation: DulaglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 53
30-Day Fills 104.0
Days Supply 3,070
MT State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills45.0
Peer Average Days Supply1,280
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 60.6% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $105,788.25 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,996.00

State Avg Cost Per Claim

$1,289.81

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment.

Tymlos

Generic Formulation: AbaloparatideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 17
30-Day Fills 17.0
Days Supply 510
MT State Average Benchmarks
Peer Average Claims12.0
Peer Average 30-Day Fills12.8
Peer Average Days Supply382
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 41.7% more claims than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $47,275.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,780.93

State Avg Cost Per Claim

$2,589.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Abaloparatide is used to treat bone loss (osteoporosis) in people who have a high risk of getting fractures. It is similar to a natural hormone in your body (parathyroid hormone). It works by increasing bone mass and strength. This effect helps to decrease the risk of getting a fracture. This medication should not be used for children or young adults whose bones are still growing.

Ulticare Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 29
30-Day Fills 63.2
Days Supply 1,868
MT State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills31.6
Peer Average Days Supply888
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 45.0% more claims than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,028.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$104.44

State Avg Cost Per Claim

$75.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Nano Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 51
30-Day Fills 116.4
Days Supply 3,466
MT State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills41.8
Peer Average Days Supply1,228
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 142.9% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,343.48 across this reporting matrix range.

Provider Avg Cost Per Claim

$104.77

State Avg Cost Per Claim

$84.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Short Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 14
30-Day Fills 31.3
Days Supply 938
MT State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills35.1
Peer Average Days Supply1,020
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,384.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$170.30

State Avg Cost Per Claim

$93.38

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Victoza 3-Pak

Generic Formulation: LiraglutideSpecialty: Endocrinology
Provider Metrics Summary
Total Claims 54
30-Day Fills 124.5
Days Supply 3,735
MT State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills28.9
Peer Average Days Supply850
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 184.2% higher than the standard regional baseline profile for MT. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $130,991.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$2,425.77

State Avg Cost Per Claim

$1,563.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Therapeutic Applications

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like BRIAN G ROSE MD provides transparency into local medical care patterns within Bozeman, MT.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Endocrinology, Diabetes & Metabolism** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.